Journal
Published in the Bulletin for NYU Hospital for Joint Diseases
In this study,24 researchers compare three economic models for treating a pool of 1,000 patients with tibia fractures. Using EXOGEN in conservative and operative treatment paths resulted in an overall savings of $14.6 million — a reduction in cost that would benefit third-party payers, employers, government agencies and patients.
Full article available at PubMed.gov or download now
White paper
International Society for Pharmacoeconomics and Outcomes Research, Seventh Annual European Congress, Hamburg, Germany
This white paper26 evaluates the expected cost of treating a non-union* fracture using five fracture stimulation devices. EXOGEN is shown to be the most cost-effective and optimal for 85% of patients.
From patients
Westfield, Ind.
How EXOGEN helped Kendra Lancaster, captain of the US Women’s Sitting Volleyball Team, get back to the game she loves.
Want to talk with an EXOGEN expert? Or learn about earning CEUs through Smith & Nephew? Contact your representative today.
Call our customer service specialists at (800) 836-4080 or contact us on the web today.
Find out how EXOGEN could help you reduce healthcare costs in our just-the-facts white paper.
Browse more resources
*Summary of Indications for Use: The EXOGEN Ultrasound Bone Healing System is indicated for the non-invasive treatment of established non-unions† excluding skull and vertebra.
In addition, EXOGEN is indicated for accelerating the time to a healed fracture for fresh, closed, posteriorly displaced distal radius fractures and fresh, closed or Grade I open tibial diaphysis fractures in skeletally mature individuals when these fractures are orthopaedically managed by closed reduction and cast immobilization.
There are no known contraindications for the EXOGEN device. Safety and effectiveness has not been established for individuals lacking skeletal maturity; pregnant or nursing women; patients with cardiac pacemakers; on fractures due to bone cancer; or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel. Full prescribing information can be found in product labeling, at www.exogen.com or by contacting customer service at 1-800-836-4080.
†A non-union is considered to be established when the fracture site shows no visibly progressive signs of healing.
Countries 